Search

Displaying results 9691 - 9700 of 10000 in total
  1. Drug

    Otilimab

    go.drugbank.com/drugs/DB06303
    Investigational

    Investigated for the treatment of osteoarthritis and rheumatoid arthritis (RA).

  2. Drug

    Naxifylline

    go.drugbank.com/drugs/DB06471
    Experimental

  3. Drug

    MC-1

    go.drugbank.com/drugs/DB05315
    Experimental

    Medicure's MC-1 drug is a cardio-protectant, designed to reduce the damage to the heart when arteries are blocked and when they are subsequently reopened after bypass surgery.

  4. Drug

    Valtorcitabine

    go.drugbank.com/drugs/DB06187
    Investigational

  5. Drug

    Celgosivir

    go.drugbank.com/drugs/DB06580
    Investigational

  6. Drug

    Sodium tripolyphosphate

    go.drugbank.com/drugs/DB11493
    InvestigationalVet approved

    Sodium tripolyphosphate is an inorganic compound with formula Na5P3O10 and the sodium salt of the polyphosphate penta-anion.

  7. Drug

    Ficlatuzumab

    go.drugbank.com/drugs/DB11680
    Investigational

    Ficlatuzumab has been used in trials studying the treatment of Acute Myeloid Leukemia, Non-small Cell Lung Cancer, Mullerian Mixed Tumor of Ovary, Relapsed Acute Myeloid Leukemia, and Refractory Acute

  8. Drug

    Onatasertib

    go.drugbank.com/drugs/DB12570
    Investigational

    Onatasertib (CC-223) has been used in trials studying the treatment and basic science of Multiple Myeloma, Glioblastoma Multiforme, HepatoCellular Carcinoma, Non-small Cell Lung Cancer, and Diffuse Large

  9. Drug

    MW33

    go.drugbank.com/drugs/DB16358
    Experimental

    [L27411] This antibody injection is currently being investigated against COVID-19 in the clinical trial NCT04533048 (A Clinical Study to Evaluate MW33 Injection).

  10. Drug

    Lavamilast

    go.drugbank.com/drugs/DB19767
    Experimental

    The usage of the INN stem '-milast' in the name indicates that Lavamilast is a Phosphodiesterase-4 (PDE4) inhibitor. Lavamilast has a monoisotopic molecular weight of 520.16 Da.